According to the study, aspirin, which dates back to 120 years and is widely used to increase blood fluidity in heart patients, does not make any difference in the death rate in relation to corona, based on a month of clinical trials that included about 15,000 volunteers, and it was quoted by the agency. “Bloomberg”.
Just one day less
The researchers also indicated that survivors of death from the disease who received aspirin spent less days in hospital compared to those who did not receive a daily dose of it, according to the German news agency.
While doctors had hoped that aspirin could help fight blood clots caused by corona in the lungs and elsewhere in the body, the results of the trial indicate that aspirin will instead join a long list of treatments that cannot be relied upon again in combating epidemic.
In turn, Martin Landray, professor of medicine and epidemiology at Oxford University, and one of the main participants in the study, showed that aspirin is inexpensive, and is widely used in other diseases to reduce the risk of blood clots, so it is disappointing that it does not have a significant impact with regard to Corona.
To join the famous drug with another group of his friends who did not achieve the desired goal in treating Corona, including hydroxychloroquine, and two anti-HIV drugs.
It is worth noting that researchers believed last year that aspirin reduces the risks of corona due to its prevention of dangerous blood clots that form in the heart, lungs, blood vessels and other organs in the body, which may lead to death due to heart attacks, strokes and the failure of multiple organs in the body to perform their functions. .
the biggest challenge
It is noteworthy that Dr. Rana Al-Hajja, Director of Programs Department at the World Health Organization in the Regional Office for the Eastern Mediterranean, revealed during the press conference, which was held yesterday, Wednesday, to monitor the latest developments on the Covid-19 epidemic caused by the Corona virus in the WHO Eastern Mediterranean Region, to The Region has reported 10,353,336 confirmed cases of COVID-19, and 206,573 deaths as of June 8, 2021.
While the total number of cases decreased over the past six weeks, and the number of deaths stabilized, 9 countries reported an increase in the number of cases last week, compared to the previous week. Of those nine countries, Somalia, Sudan and Afghanistan reported the highest increase in cases, and 11 countries reported an increase in deaths last week, with Sudan, Afghanistan and Morocco seeing the highest increase.
In addition, pandemic control across the Region is challenging due to a number of reasons, including: the emergence of new mutations, the stress caused by COVID-19, and the lack of commitment by many to public health and social measures. However, one of the biggest challenges is the continued spread of rumors and misinformation.